Guy Ayadokoun

Guy is working on a Mendelian randomization study focused on drug repurposing for type 1 diabetes. His work combines genetic data analysis, multi-omics data integration, and the development of computational tools to identify therapeutic targets based on human biology.

Before pursuing his master's degree in bioinformatics at the Université de Montréal, Guy completed a bachelor's degree in software engineering at the Université d'Abomey-Calavi, where he specialized in front-end development.